Real-world evidence supporting the use of advanced hybrid closed loop in poorly controlled type 1 diabetes patients
Graf S, Hofer G, Hirschmann R, et al.
Diabetes Res Clin Pract. 2025:112035.
Leggi
Efficacy and hypoglycaemia outcomes with once-weekly insulin icodec versus once-daily basal insulin in individuals with type 2 diabetes by kidney function: a post hoc participant-level analysis of the ONWARDS 1-5 trials
Rossing P, Benamar M, Cheng AYY, et al.
Diabetes Obes Metab. Pub. online 10 Feb 2025.
Leggi
Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in Italy
Catarinella D, Melzi R, Mercalli A, et al.
Lancet Diabetes Endocrinol. Pub. online 6 Feb 2025.
Leggi
Lung function impairment and risks of incident cardiovascular diseases and mortality among people with type 2 diabetes: a prospective cohort study
Chen C, Huang Z, Liu L, et al.
Diabetes Care. 2025:dc242188.
Leggi
Alzheimer disease blood biomarkers and cognition among individuals with diabetes and overweight or obesity
Mielke MM, Evans JK, Neiberg RH, et al.
JAMA Netw Open. 2025;8(2):e2458149.
Leggi
Safety and effectiveness of MiniMed™ 780G advanced hybrid closed-loop insulin intensification in adults with insulin-requiring type 2 diabetes
Bhargava A, Bergenstal RM, Warren ML, et al.
Diabetes Technol Ther. Pub. online 6 Feb 2025.
Leggi
Repeated OGTT versus continuous glucose monitoring for predicting development of stage 3 type 1 diabetes: a longitudinal analysis
Desouter AK, Keymeulen B, Van de Velde U, et al.
Diabetes Care. 2025 Feb 4:dc242376.
Leggi
Cardiometabolic trajectories preceding dementia in community-dwelling older individuals
Wu Z, Cribb L, Wolfe R, et al.
JAMA Netw Open. 2025;8(2):e2458591.
Leggi